Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Q2 Review: Big Pharmas Weigh In On M&A, Pricing Reform

Jul 30 2019

• By Mary Jo Laffler and Joseph Haas

Quarterly resluts on typewriter close up

Related Content

Impact Of Higher Part D Donut Hole Discounts Beginning To Show: Xarelto Sales Down 19%

Jul 17 2019

New Payment Models For Curative Treatments Have CMS’ Attention, Verma Says

May 23 2019

A Complete Retreat: “Protected Classes” Stay Protected In US Medicare

May 21 2019

Roche's Hemlibra Wins Expanded FDA Approval, Opening The Door To Broad Hemophilia A Opportunity

Oct 04 2018

US Market For Therapeutic Cancer Biosimilars Will Be Tested By Mvasi, Kanjinti Launches

Jul 19 2019

Merck Positions MK-8591 As Backbone For HIV Treatment And Prophylaxis

Jul 24 2019

$5bn Galapagos Deal Won’t Be Last For Gilead, Says O’Day

Jul 15 2019

Amgen's KRAS Inhibitor AMG 510 Leans Toward Tumor-Dependent, Not Agnostic, Approach

Jun 04 2019

Hudson To Succeed Brandicourt As Sanofi CEO

Jun 07 2019

Deal Watch: Vertex Expands Gene-Editing Efforts With A Pair Of Deals

Jun 10 2019

Lartruvo Could Be A Failure Of The Drug, The Design Or The Disease

Jun 04 2019

Dupixent Gets Room To Grow With New Indication In Chronic Rhinosinusitis

Jun 26 2019

Roche Makes Case For Its Oral SMA Drug Risdiplam As Filings Beckon

Feb 06 2019

Lilly’s CVOT Success With Trulicity Causes Bullish Outlook For Diabetes Franchise

Nov 06 2018

Merck Buys Peloton On Eve Of IPO, Expands Kidney Cancer Portfolio

May 22 2019

Biktarvy, PrEP Continue Driving Gilead’s HIV Dominance

May 03 2019

Novartis' Kisqali Scores Big Win In Competitive CDK4/6 Space

Jun 01 2019

Related Companies

Pfizer Inc.

Viatris Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

AbbVie Inc.

Allergan plc

Merck & Co., Inc.

Merck & Co., Inc.

AstraZeneca PLC

Gilead Sciences, Inc.

Galapagos NV

Amgen, Inc.

Eli Lilly and Company

Novartis AG

Sanofi

Sanofi

Biogen, Inc.

Lexicon Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

Additional Topics

Sales & Earnings Biosimilars Business Strategies Companies Deals Commercial BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window